Bacil Pharma Shareholding

Bacil Pharma Ltd Shareholding Pattern

The Bacil Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bacil Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Bacil Pharma Ltd (NSE: , BSE: 524516) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bacil Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Bacil Pharma Ltd Shareholding Pattern (Latest)

The latest Bacil Pharma Ltd shareholding for Mar 2026 is:

• Promoters: 0%
• FII: 0%
• DII: 0%
• Public: 100%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Bacil Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Bacil Pharma Ltd.

• Mar 2026: 0%
• Dec 2025: 0.08%
• Sept 2025: 0.08%
• Jun 2025: 0.20%
• Mar 2025: 0.20%

Promoter stake remains largely stable, showing consistent ownership structure.

Bacil Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bacil Pharma Ltd.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Bacil Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0%
• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%

DII holdings remain stable, reflecting steady institutional participation.

Bacil Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 100%
• Dec 2025: 99.92%
• Sept 2025: 99.92%
• Jun 2025: 99.80%
• Mar 2025: 99.80%

Public participation in Bacil Pharma Ltd has increased, indicating rising retail investor interest.

Bacil Pharma Ltd Government Holding

Government holding in Bacil Pharma Ltd currently stands at 0%.

Bacil Pharma Ltd operates without significant government ownership.

Bacil Pharma Ltd Shareholding Analysis Summary

The Bacil Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Bacil Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Bacil Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.